To elucidate the correlations of possible causative factors such as EPO levels, tumor size and cystic formations, co-morbidities and VHL mutation specificity in patients with hemangioblastomas, we systematically investigated a consecutive series of patients operated on hemangioblastomas in our department. The gene discussed is EPO; the disease is hemangioblastoma.